Sovereign Financial Group, Inc. Seelos Therapeutics, Inc. Transaction History

Sovereign Financial Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$0.16 - $1.64 $6,400 - $65,600	-40,000 Reduced 66.67%	20,000 $3,000
Q2 2023 Jul 31, 2023	SELL	$0.66 - $1.22 $9,900 - $18,300	-15,000 Reduced 20.0%	60,000 $72,000
Q1 2022 May 16, 2022	BUY	$0.84 - $1.71 $63,000 - $128,250	75,000 New	75,000 $63,000
Q4 2021 Feb 15, 2022	SELL	$1.59 - $2.38 $31,800 - $47,600	-20,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.69 - $2.89 $33,800 - $57,800	20,000 New	20,000 $48,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $32M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Sovereign Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Sovereign Financial Group, Inc. with notifications on news.